| 英文别名 |
Trandolapril;(2s,3ar,7as)-1-[(2s)-2-[[(1s)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;RU44570;(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid;(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid,form I crystalline polymorph of;1-[2-[(1-ethoxycarbonyl-3-phenylpropyl)amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;Odrik;Preran;Trandolaprilum [Latin];Mavik;(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid;(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid (ACI);1H-Indole-2-carboxylic acid, 1-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, [2S-[1[R*(R*)],2α,3aα,7aβ]]- (ZCI);Gopten;RU 44570;s6468;TRANDOLAPRIL [MART.];TRANDOLAPRIL (EP MONOGRAPH);Trandolapril Tablets;KS-1467;Tox21_111453;NCGC00182079-03;(2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid;TRANDOLAPRIL COMPONENT OF TARKA;NS00001070;RU-44570;(2S,3aR,7aS)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)octahydro-1H-indole-2-carboxylic acid;87679-37-6;CCRIS 6594;Trandolapril [USP:INN:BAN];NCGC00095153-01;TRANDOLAPRIL [USP-RS];GTPL6453;Udrik;Trandolapril (JAN/USP/INN);Trandolapril; (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid;LP00924;TRANDOLAPRIL [MI];(2s,3ar,7as)-1-[(2s)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1h-indole-2-carboxylic acid;HSDB 8392;NSC 758939;DTXSID2023692;TRANDOLAPRIL [ORANGE BOOK];NCGC00182079-02;(2S,3aR,7aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)hexahydro-2-indoline carboxylic acid;(2S,3aR,7aS)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydro-1H-indole-2-carboxylic acid;SR-02000000917;TRANDOLAPRIL [VANDF];NCGC00182079-09;Q929420;Trandolaprilum (Latin);CHEMBL1519;Odric;Tox21_500924;SCHEMBL16610;TRANDOLAPRIL (USP-RS);TRANDOLAPRIL [JAN];TARKA COMPONENT TRANDOLAPRIL;1H-Indole-2-carboxylic acid, 1-((2S)-2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S,3aR,7aS)-;Trandolapril, United States Pharmacopeia (USP) Reference Standard;Trandolapril, European Pharmacopoeia (EP) Reference Standard;Trandolapril (USP:INN:BAN);DTXCID003692;C09AA10;HY-B0592;Tox21_113152;EN300-7481395;AKOS015843316;SDCCGSBI-0633768.P001;2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid, M... |